Finance

Lists
Q2 2026 earnings • released • EPS beat +3.13% • Revenue miss -3.71%
See results
RNST:NYSE
Renasant Corp
$43.57
+0.53%
(+0.23) 1D
$43.57
0.00% (0.00)
After hours
Closed: Jul 31, 4:00:06 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for RNST...
Open
$43.20
High
$43.58
Low
$42.91
Mkt. cap
3.98B
Avg. vol.
752.38K
Volume
605.26K
Dividend
2.20%
Quarterly dividend
$0.24
Ex-dividend date
Jun 16, 2026
P/E ratio
13.06
52-wk high
$44.50
52-wk low
$33.04
EPS
$3.34
Beta
0.96
Shares outstanding
92.27M
No. of employees
3K
Open
$43.20
High
$43.58
Low
$42.91
Mkt. cap
3.98B
Avg. vol.
752.38K
Volume
605.26K
Dividend
2.20%
Quarterly dividend
$0.24
Ex-dividend date
Jun 16, 2026
P/E ratio
13.06
52-wk high
$44.50
52-wk low
$33.04
EPS
$3.34
Beta
0.96
Shares outstanding
92.27M
No. of employees
3K
News stories
From sources across the web
About Renasant Corp
CEO-
Employees3K
Founded1904
HeadquartersTupelo, Mississippi, United States
SectorBank
Websiteinvestors.renasant.com
Analyst ratings
Based on 3 analysts giving stock ratings to RNST in the past 3 months
Strong buy
Buy
3
Hold
0
Sell
0
12-month forecast
Based on 3 Wall Street analysts offering 12 month price targets for RNST in the last 3 months.
Highest
Current $43.57
$49.00 (+12.46%)
Average
$48.00 (+10.17%)
Lowest
$47.00 (+7.87%)
Analyst
Recommendation
Action
Price target
Projected
Date
Catherine Mealor
KBW
Buy
Maintained
$47.00
+7.9%
07/31/2026
Janet Lee
TD Cowen
Buy
Reiterated
$49.00
+12.5%
07/30/2026
Stephen Scouten
Piper Sandler
Buy
Maintained
$48.00
+10.2%
07/30/2026
Unknown Analyst
Stephens
Buy
Maintained
$43.00
-1.3%
01/28/2026
Last report
Jul 29, 2026
Fiscal period
Q2 2026
EPS / Est. (USD)
$0.94 / $0.91
+3.13%beat
Revenue / Est. (USD)
270.14M / 280.55M
-3.71%miss
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
259.10M
267.58M
265.75M
270.14M
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
135.58M
132.98M
128.01M
132.04M
Operating expense
157.33M
151.24M
145.71M
152.68M
Total operating expenses
157.33M
151.24M
145.71M
152.68M
Operating income
101.76M
116.35M
120.04M
117.47M
Other non operating income
-9.00M
-8.95M
-9.62M
-8.82M
EBT including unusual items
75.27M
96.83M
110.42M
108.64M
EBT excluding unusual items
92.76M
107.40M
110.42M
108.64M
Income tax expense
15.48M
17.88M
22.20M
21.55M
Effective tax rate
20.56%
18.47%
20.10%
19.84%
Other operating expenses
21.75M
18.26M
17.70M
20.63M
Net income
59.79M
78.95M
88.23M
87.09M
Net profit margin
23.08%
29.50%
33.20%
32.24%
Earnings per share
0.77
0.91
0.93
0.94
Interest and investment income
-
-
-
-
Interest expense
-
-
-
-
Net interest expenses
-
-
-
-
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-5.27M
-7.39M
-5.30M
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps